DarioHealth Corp.
DarioHealth Corp. (DRIO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
drio · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$16.00
Consensus
$12.50
+68.6% upside
Low
$7.50
Median: $14 · Last Close: $7.42
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$12.50
68.6% upside
High Target
$16
115.8%
Low Target
$7.5
1.1%
Current Price
$7.42
as of today
Based on analyst price targets, the DRIO stock price prediction for the next 12 months ranges from $7.5 to $16. The consensus DRIO price forecast of $12.50 implies 68.6% upside from the current price of $7.42.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.26 | ↓ 2.11% |
1-day model range: $7.14–$7.37. Peak: $7.37 (-2.11%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · DRIO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-14 | Stifel | Maintains | Buy→Buy |
| 2026-05-13 | TD Cowen | Maintains | Hold→Hold |
| 2026-03-20 | Stifel | Maintains | Buy→Buy |
| 2025-03-11 | Stifel | Maintains | Buy→Buy |
| 2024-04-01 | Stifel | Maintains | Buy→Buy |
| 2023-08-11 | Alliance Global Partners | Maintains | Buy→Buy |
| 2023-07-25 | Stifel | Maintains | Buy→Buy |
| 2023-05-12 | Craig-Hallum | Maintains | Buy→Buy |
| 2022-11-16 | Alliance Global Partners | Maintains | Buy→Buy |
| 2022-08-18 | Aegis Capital | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on DarioHealth Corp. (DRIO) stock. Of the recent 29 rating actions, 1 were upgrades and 0 were downgrades. 9 analysts currently cover DRIO.
Analyst Recommendation Trends
DRIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$26M
↓ 50.9% YoY
Revenue Next Year
$38M
↑ 46.1% YoY
EPS This Year
$-3.71
EPS Next Year
$-1.94
↓ 47.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast DRIO EPS of $-3.71 for the current fiscal year, based on estimates from 2 analysts. The DRIO revenue forecast is $26M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DRIO stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DRIO price target is $12.50 (+68.6% upside), with an analyst consensus of Buy.
The DRIO short-term stock prediction for tomorrow is $7.26 (-2.11%).
DarioHealth Corp. trades on NASDAQ under the ticker DRIO. The DRIO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.
Frequently asked questions
DRIO forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month DRIO price target is $12.50, with a high forecast of $16.00 and a low of $7.50. The median price target is shown in the chart above when available. This implies +68.6% potential upside from the current price of $7.42.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.